Construction of an expression vector for production of tissue plasminogen activator (t-PA) in a transgenic microalgae bioreactor
نویسندگان
چکیده
Microalgae systems have opened up new platforms for molecular farming in closed conditions. Recently, Dunaliella salina has been considered to be a suitable expression host for the production of recombinant proteins due to its significant advantages. It is a unicellular eukaryotic organism lacking cell wall and having post-translational processing for proteins which can grow in high salinity environments. To construct an expression vector, different fragments including Ubiquitin promoter, the gene of interest (t-PA; K2 and S domains), Omega leader sequences, KDEL, 6-Histidine tag, SYQ and Nos terminator (as the stop signal for gene transcription) were considered in upstream strategy. pCAMBIA 3301 and 1304 plasmids which contained bar gene (phosphinothricin resistance gene as a plant selectable marker) were used as the framework for construction of the expression vector and driving the expression of gene of interest. Further studies are undergoing to transform the constructed vector into D.salina.
منابع مشابه
بهینهسازی تولید فعالکننده پلاسمینوژن بافتی نوترکیب در انگل لیشمانیای غیر بیماریزا با طراحی دو سازۀ ژنی
Background: Recombinant tissue plasminogen activator (rt-PA) is one of the most important thrombolytic agentsused in patients with vascular occlusions such as acute ischemic stroke or myocardial infarction. A variety of recombinant protein expression systems have been developed for heterologous gene expression in prokaryotic and eukaryotic hosts. In recent years, Leishmania tarentolae (L. tare...
متن کاملOptimizing refolding condition for recombinant tissue plasminogen activator
Low molecular size additives such as L-arginine and the redox compounds have been used both in the culturemedium and in vitro refolding to increase recombinant proteins production. Additives increase proteinrefolding and yield of active proteins by suppressing aggregate formation or enhancing refolding process.In this work, a comparative study was performed on refolding of rec...
متن کاملA clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors
Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...
متن کاملDual frequency ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro human clot model
Introduction: Stroke causes death and disability in patients throughout the world. At present, the only FDA- approved drug for ischemic stroke is recombinant tissue plasminogen activator (rt- PA). Unfortunately, rtPA can cause intracerebral hemorrhage and must use within limited time window (within 3-4.5 hour after onset of stroke). Ultrasound with rtPA loaded liposomes (rtPA_L...
متن کاملActive Expression of Human Tissue Plasminogen Activator (t-PA) c-DNA from Pulmonary Metastases in the Methylotrophic Yeast Pichia Pastoris KM71H Strain
Background: Human tissue-type plasminogen activator (t-PA) is a key protease of the trypsin family. It catalyzes the activation of zymogen plasminogen to the fibrin-degrading proteinase, plasmin, leading to digestion of fibrin clots. The recombinant enzyme produced by recombinant technology issued to dissolve blood clots in treatment of various human diseases such as coronary artery thrombosis,...
متن کامل